Brief: Hofseth Biocare Q2 Operating Loss at NOK 18.3 Million
Aug 27 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* Q2 OPERATING REVENUE NOK 14.6 MILLION VERSUS NOK 5.5
MILLION
YEAR AGO
* Q2 OPERATING LOSS NOK 18.3 MILLION VERSUS LOSS NOK 18.4
MILLION YEAR AGO
* SAYS WILL CONTINUE TO INCREASE PRODUCTION VOLUMES IN THE
NEXT
QUARTERS
Source text for Eikon: ID:nGNE3QHMb6
Further company coverage: HOFBC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering